Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AF0E | ISIN: US24906P1093 | Ticker-Symbol: DY2
Tradegate
10.05.24
19:18 Uhr
25,880 Euro
-0,020
-0,08 %
1-Jahres-Chart
DENTSPLY SIRONA INC Chart 1 Jahr
5-Tage-Chart
DENTSPLY SIRONA INC 5-Tage-Chart
RealtimeGeldBriefZeit
25,58026,22010.05.
25,78026,01010.05.

Aktuelle News zur DENTSPLY SIRONA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiDENTSPLY SIRONA Inc.: Dentsply Sirona to Participate in Upcoming Investor Conferences3
MoKey Takeaways From Dentsply Sirona Analyst Ratings7
03.05.DENTSPLY SIRONA Inc. (XRAY) Q1 2024 Earnings Call Transcript4
03.05.Earnings call: DENTSPLY SIRONA faces mixed Q1 results, maintains full-year outlook5
02.05.Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results5
02.05.DENTSPLY SIRONA Inc reports results for the quarter ended in March - Earnings Summary6
02.05.Dentsply Sirona Falls Over 4% Following Q1 Results - Read Why7
02.05.DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y2
02.05.DENTSPLY SIRONA Inc. - 10-Q, Quarterly Report4
02.05.Dentsply Sirona Inc Q1 Earnings Summary172YORK (PENNSYLVANIA) (dpa-AFX) - Below are the earnings highlights for Dentsply Sirona Inc (XRAY):Earnings: $18 million in Q1 vs. -$19 million in the same period last year. EPS: $0.09 in Q1...
► Artikel lesen
02.05.DENTSPLY SIRONA Inc. - 8-K, Current Report1
02.05.Dentsply Sirona Non-GAAP EPS of $0.42 in-line, revenue of $953M misses by $15.77M6
02.05.DENTSPLY SIRONA Inc.: Dentsply Sirona Reports First Quarter 2024 Results81Net sales of $953 million decreased (2.6%), organic sales decreased (1.9%)GAAP gross margin of 53.1%, GAAP net income of $18 million or $0.09 per shareAdjusted EBITDA margin of 16.8%, adjusted EPS...
► Artikel lesen
01.05.Dentsply Sirona Q1 2024 Earnings Preview1
30.04.What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?2
30.04.DENTSPLY SIRONA Inc expected to post earnings of 42 cents a share - Earnings Preview1
18.04.A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts10
09.04.DENTSPLY SIRONA Inc.: Dentsply Sirona to Host First Quarter Conference Call on May 2nd8
02.04.Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now10
28.03.S&P Dow Jones Indices: GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600280NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE: SOLV) will be added...
► Artikel lesen
Seite:  Weiter >>
65 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1